%0 Journal Article
%T A phase II multicentre study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-programmed cell death 1 antibody-refractory malignant melanoma: TM5614-MM trial
%A Fujimura, Taku
%A Yoshino, Koji
%A Kato, Hiroshi
%A Fukushima, Satoshi
%A Ishizuki, Shoichiro
%A Otsuka, Atsushi
%A Matsushita, Shigeto
%A Amagai, Ryo
%A Muto, Yusuke
%A Yamazaki, Emi
%A Kambayashi, Yumi
%A Yahata, Takashi
%A Miyata, Toshio
%A Fujisawa, Yasuhiro
%A Asano, Yoshihide
%J British Journal of Dermatology
%V 191
%N 5
%P 691-697
%@ 0007-0963
%D 2024-06-04
%I Oxford University Press
%~ DeepDyve